REG-Bioventix Plc: Director Dealing

BioventixAnnouncement

27/10/2022 07:15

Bioventix plc

(“Bioventix” or “the Company”)

Director Dealing

Bioventix plc (BVXP), a UK company specialising in the development and
commercial supply of high-affinity monoclonal antibodies for applications in
clinical diagnostics, announces that it has been notified that Bruce Hiscock,
Chief Financial Officer of the Company, completed the following dealings in
the Company’s ordinary shares of 5 pence in the Company ("Ordinary Shares"):
* the transfer, via sale and purchase, of 204 Ordinary Shares into his ISA. Mr
Hiscock sold 204 Ordinary Shares at a price of £33.41 from an account in his
own name and bought 204 Ordinary Shares at a price of £34.00 to be held in
his ISA; and
* the additional purchase of 276 Ordinary Shares at a price of £34.00 into
his ISA.
Following these transactions, Mr Hiscock’s total beneficial interest in the
Company is now 700 Ordinary Shares, representing approximately 0.01 per cent.
of the Company’s total issued share capital.

For further information please contact:

 Bioventix plc Peter Harrison                                 Chief Executive Officer  Tel: 01252 728 001  
                                                                                                           
 finnCap Ltd Geoff Nash/Simon Hicks/Abigail Kelly Alice Lane  Corporate Finance ECM    Tel: 020 7220 0500  

   

 1.         Details of the person discharging managerial responsibilities / person closely associated                                                                                                             
 a)         Name                                                                                               Bruce Hiscock                                                                                      
 2.         Reason for the Notification                                                                                                                                                                           
 a)         Position/status                                                                                    Chief Financial Officer                                                                            
 b)         Initial notification/Amendment                                                                     Initial notification                                                                               
 3.         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                         
 a)         Name                                                                                               Bioventix plc                                                                                      
 b)         LEI                                                                                                213800225MHX7LZQY108                                                                               
 4.         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted     
 a)         Description of the Financial instrument, type of instrument                                        Ordinary Shares                                                                                    
            Identification code                                                                                GB00B4QVDF07                                                                                       
 b)         Nature of the transaction                                                                          Sale of Ordinary Shares                                                                            
 c)         Price(s) and volume(s)                                                                                                                                                                                
 Volume(s)  Prices (pence)                                                                                     
 204        3,341                                                                                              
 d)         Aggregated information: ·Aggregated volume ·Price                                                  Sale of 204 Ordinary Shares at a price of 3,341p per Ordinary Share                                
 e)         Date of the transaction                                                                            26 October 2022                                                                                    
 f)         Place of the transaction                                                                           London Stock Exchange, AIM Market (XLON)                                                           

   

 1.         Details of the person discharging managerial responsibilities / person closely associated                                                                                                             
 a)         Name                                                                                               Bruce Hiscock                                                                                      
 2.         Reason for the Notification                                                                                                                                                                           
 a)         Position/status                                                                                    Chief Financial Officer                                                                            
 b)         Initial notification/Amendment                                                                     Initial notification                                                                               
 3.         Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                         
 a)         Name                                                                                               Bioventix plc                                                                                      
 b)         LEI                                                                                                213800225MHX7LZQY108                                                                               
 4.         Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted     
 a)         Description of the Financial instrument, type of instrument                                        Ordinary Shares                                                                                    
            Identification code                                                                                GB00B4QVDF07                                                                                       
 b)         Nature of the transaction                                                                          Purchase of Ordinary Shares                                                                        
 c)         Price(s) and volume(s)                                                                                                                                                                                
 Volume(s)  Prices (pence)                                                                                     
 480        3,400                                                                                              
 d)         Aggregated information: ·Aggregated volume ·Price                                                  Purchase of 480 Ordinary Shares at a price of 3,400p per Ordinary Share                            
 e)         Date of the transaction                                                                            26 October 2022                                                                                    
 f)         Place of the transaction                                                                           London Stock Exchange, AIM Market (XLON)                                                           



Copyright (c) 2022 PR Newswire Association,LLC. All Rights Reserved